Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001855940 | SCV002168338 | uncertain significance | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 208 of the GNAT2 protein (p.Arg208Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with achromatopsia (PMID: 31058429). ClinVar contains an entry for this variant (Variation ID: 623279). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GNAT2 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Molecular Genetics Laboratory, |
RCV000761404 | SCV000891388 | uncertain significance | Achromatopsia 4 | 2018-06-12 | no assertion criteria provided | research |